Grégory Resch

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


58 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 | 2004 | 2003 | 2002 | 1999 | 1998 |
2024
Optical Trapping and Fast Discrimination of Label-Free Bacteriophages at the Single Virion Level.
Villa N., Tartari E., Glicenstein S., de Villiers de la Noue H., Picard E., Marcoux P.R., Zelsmann M., Resch G., Hadji E., Houdré R., 2024/07. Small, 20 (27) pp. e2308814. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_26933CEB5DF3]
 
Between Centralization and Fragmentation: The Past, Present, and Future of Phage Collections
Resch Grégory, Brives Charlotte, Debarbieux Laurent, Hodges Francesca E., Kirchhelle Claas, Laurent Frédéric, Moineau Sylvain, Martins Ana Filipa Moreira, Rohde Christine, 2024/03/01. PHAGE, 5 (1) pp. 22-29.
[DOI][WoS][serval:BIB_4802BE8FD256]
Editorial: Standards in personalized phage therapy: from phage collection to phage production.
Kiljunen S., Resch G., 2024. Frontiers in cellular and infection microbiology, 14 p. 1376386. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_494984BDFD46]
2023
 
From microbiome composition to functional engineering, one step at a time.
Burz S.D., Causevic S., Dal Co A., Dmitrijeva M., Engel P., Garrido-Sanz D., Greub G., Hapfelmeier S., Hardt W-D, Hatzimanikatis V. et al., 2023/12/20. Microbiology and molecular biology reviews, 87 (4) pp. e0006323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_422DE1C48246]
Phage activity against Staphylococcus aureus is impaired in plasma and synovial fluid.
Mutti M., Moreno D.S., Restrepo-Córdoba M., Visram Z., Resch G., Corsini L., 2023/10/24. Scientific reports, 13 (1) p. 18204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_183FA57EA7AC]
Author Correction: Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa.
Köhler T., Luscher A., Falconnet L., Resch G., McBride R., Mai Q.A., Simonin J.L., Chanson M., Maco B., Galiotto R. et al., 2023/07/24. Nature communications, 14 (1) p. 4443. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_523E349B3A6F]
Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa.
Köhler T., Luscher A., Falconnet L., Resch G., McBride R., Mai Q.A., Simonin J.L., Chanson M., Maco B., Galiotto R. et al., 2023/06/27. Nature communications, 14 (1) p. 3629. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D83C8FB61C7C]
2022
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations.
Mitropoulou G., Koutsokera A., Csajka C., Blanchon S., Sauty A., Brunet J.F., von Garnier C., Resch G., Guery B., 2022/12/31. European respiratory review, 31 (166) p. 220121. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E890AE6D6C1D]
Phagothérapie pour traiter les infections respiratoires [Phage therapy for respiratory infections]
Mitropoulou G., Gijs P.J., Koutsokera A., Sauty A., Blanchon S., Csajka C., Brunet J.F., Resch G., Guery B., Von Garnier C., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2150-2156. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CCFF1CBAD0AE]
Identification and Characterization of Erwinia Phage IT22: A New Bacteriophage-Based Biocontrol against Erwinia amylovora.
Sabri M., El Handi K., Valentini F., De Stradis A., Achbani E.H., Benkirane R., Resch G., Elbeaino T., 2022/11/05. Viruses, 14 (11). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0DD606476BEB]
Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Infective Endocarditis.
Save J., Que Y.A., Entenza J., Resch G., 2022/08/16. Viruses, 14 (8) p. 1792. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A083F3FD86C1]
Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection.
Ferry T., Kolenda C., Laurent F., Leboucher G., Merabischvilli M., Djebara S., Gustave C.A., Perpoint T., Barrey C., Pirnay J.P. et al., 2022/07/22. Nature communications, 13 (1) p. 4239. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7F7461B53275]
 
Benefits of Aerosolized Phages for the Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus: An Experimental Study in Rats.
Prazak J., Valente L.G., Iten M., Federer L., Grandgirard D., Soto S., Resch G., Leib S.L., Jakob S.M., Haenggi M. et al., 2022/04/19. The Journal of infectious diseases, 225 (8) pp. 1452-1459. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F570F4032F88]
Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin Act Synergistically Against Staphylococcus aureus Experimental Infective Endocarditis.
Save J., Que Y.A., Entenza J.M., Kolenda C., Laurent F., Resch G., 2022/02. Journal of the American Heart Association, 11 (3) pp. e023080. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_28CEC1719C12]
 
Recent progress toward the implementation of phage therapy in Western medicine.
Pirnay J.P., Ferry T., Resch G., 2022/01/18. FEMS microbiology reviews, 46 (1) pp. fuab040. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BDE03CF6EB6D]
Efficacy assessment of a novel endolysin PlyAZ3aT for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat model.
Valente L.G., Le N.D., Pitton M., Chiffi G., Grandgirard D., Jakob S.M., Cameron D.R., Resch G., Que Y.A., Leib S.L., 2022. PloS one, 17 (4) pp. e0266928. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A33C7C8026C9]
2021
Unpuzzling Friunavirus-Host Interactions One Piece at a Time: Phage Recognizes Acinetobacter pittii via a New K38 Capsule Depolymerase.
Domingues R., Barbosa A., Santos S.B., Pires D.P., Save J., Resch G., Azeredo J., Oliveira H., 2021/10/26. Antibiotics, 10 (11) p. 1304. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F188454F68EC]
Complete Genome Sequence of Pseudomonas Phage Zikora.
Ezemokwe C.G., Agwom F.M., Okoliegbe I., Okonkwo F.O., Ngene A.C., Gimba N., Morenikeji O.R., Egwuenu A., Okonkwo C.H., Aguiyi J.C. et al., 2021/07/29. Microbiology resource announcements, 10 (30) pp. e0048921. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62D87F751BD6]
ε2-Phages Are Naturally Bred and Have a Vastly Improved Host Range in Staphylococcus aureus over Wild Type Phages
Sáez Moreno D., Visram Z., Mutti M., Restrepo-Córdoba M., Hartmann S., Kremers A.I., Tišáková L., Schertler S., Wittmann J., Kalali B. et al., 2021/04/02. Pharmaceuticals, 14 (4) p. 325. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B1D944FF910]
Engineered Phage Endolysin Eliminates Gardnerella Biofilm without Damaging Beneficial Bacteria in Bacterial Vaginosis Ex Vivo.
Landlinger C., Tisakova L., Oberbauer V., Schwebs T., Muhammad A., Latka A., Van Simaey L., Vaneechoutte M., Guschin A., Resch G. et al., 2021/01/08. Pathogens, 10 (1) pp. E54. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA638C21B4B1]
Isolation and characterization of bacteriophages from the human skin microbiome that infect Staphylococcus epidermidis.
Valente L.G., Pitton M., Fürholz M., Oberhaensli S., Bruggmann R., Leib S.L., Jakob S.M., Resch G., Que Y.A., Cameron D.R., 2021. FEMS microbes, 2 pp. xtab003. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3E18DFB614B8]
Phage susceptibility testing and infectious titer determination through wide-field lensless monitoring of phage plaque growth.
Perlemoine P., Marcoux P.R., Picard E., Hadji E., Zelsmann M., Mugnier G., Marchet A., Resch G., O'Connell L., Lacot E., 2021. PloS one, 16 (3) pp. e0248917. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5530A2C8405D]
The multidomain architecture of a bacteriophage endolysin enables intramolecular synergism and regulation of bacterial lysis.
Oechslin F., Menzi C., Moreillon P., Resch G., 2021. The Journal of biological chemistry, 296 p. 100639. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6FAFABEE4035]
2020
Reusability of filtering facepiece respirators after decontamination through drying and germicidal UV irradiation.
Vernez D., Save J., Oppliger A., Concha-Lozano N., Hopf N.B., Niculita-Hirzel H., Resch G., Michaud V., Dorange-Pattoret L., Charrière N. et al., 2020/10. BMJ global health, 5 (10) pp. e003110. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A06FF4915219]
Characterization and Lytic Activity of Isolated Escherichia coli Bacteriophages against Escherichia coli in vitro.
Rahimzadeh G., Resch G., Rezai M.S., Nemati Hevelaee E., 2020/07. Iranian journal of medical sciences, 45 (4) pp. 298-303. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E641F8D5E361]
Combined Bacteriophage and Antibiotic Treatment Prevents Pseudomonas aeruginosa Infection of Wild Type and cftr- Epithelial Cells.
Luscher A., Simonin J., Falconnet L., Valot B., Hocquet D., Chanson M., Resch G., Köhler T., van Delden C., 2020. Frontiers in microbiology, 11 p. 1947. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4727BFFC750]
Editorial: Manufacturing, Formulation and Delivery Issues for Phage Therapy to Become A Reality.
Malik D.J., Resch G., 2020. Frontiers in microbiology, 11 p. 584137. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_76E7A5271D8D]
2019
 
Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia.
Leshkasheli L., Kutateladze M., Balarjishvili N., Bolkvadze D., Save J., Oechslin F., Que Y.A., Resch G., 2019/12. Journal of global antimicrobial resistance, 19 pp. 255-261. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A99574873386]
 
Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-associated Pneumonia.
Prazak J., Iten M., Cameron D.R., Save J., Grandgirard D., Resch G., Goepfert C., Leib S.L., Takala J., Jakob S.M. et al., 2019/11/01. American journal of respiratory and critical care medicine, 200 (9) pp. 1126-1133. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2CF5B9B31B06]
Draft Genome Sequence of Methicillin-Resistant Staphylococcus aureus Strain AW7, Isolated from a Patient with Bacteremia.
Cameron D.R., Ramette A., Prazak J., Entenza J., Haenggi M., Que Y.A., Resch G., 2019/10/03. Microbiology resource announcements, 8 (40). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_52D0AC9F4BCB]
 
Infectiologie sur mesure - 2. Phagothérapie : de la théorie à l’évidence clinique [Customised infectiology - Phage therapy: from theory to clinical evidence]
Desgranges F., Bochud P.Y., Resch G., 2019/04/10. Revue medicale suisse, 15 (646) pp. 771-775. Peer-reviewed.
[Pmid][serval:BIB_CDA00DF78395]
Genotypes of Staphylococcus aureus: On-farm epidemiology and the consequences for prevention of intramammary infections.
Leuenberger A., Sartori C., Boss R., Resch G., Oechslin F., Steiner A., Moreillon P., Graber H.U., 2019/04. Journal of dairy science, 102 (4) pp. 3295-3309. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8273E297CF5A]
Complete Genome Sequences of Five Acinetobacter baumannii Phages from Abidjan, Côte d'Ivoire.
Essoh C., Vernadet J.P., Vergnaud G., Coulibaly A., Kakou-N'Douba A., N'Guetta A.S., Resch G., Pourcel C., 2019/01. Microbiology resource announcements, 8 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_21AFA6241582]
 
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P., Leclerc T., Jennes S., Pirnay J.P., Que Y.A., Resch G., Rousseau A.F., Ravat F., Carsin H., Le Floch R. et al., 2019/01. The Lancet. Infectious diseases, 19 (1) pp. 35-45. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EA514AD32354]
 
Exploration of multiclass and one-class learning methods for prediction of phage-bacteria interaction at strain level
Carvalho Leite Diogo Manuel, Lopez Juan Fernando, Brochet Xavier, Barreto-Sanz Miguel, Que Yok-Ai, Resch Grégory, Peña-Reyes Carlos, 2019. dans Proceedings - 2018 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2018.
[DOI][serval:BIB_9298EA1FE9D1]
Spatial structure affects phage efficacy in infecting dual-strain biofilms of Pseudomonas aeruginosa.
Testa S., Berger S., Piccardi P., Oechslin F., Resch G., Mitri S., 2019. Communications biology, 2 p. 405. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_54BD1C32D6A7]
2018
Computational prediction of inter-species relationships through omics data analysis and machine learning.
Leite DMC, Brochet X., Resch G., Que Y.A., Neves A., Peña-Reyes C., 2018. BMC Bioinformatics, 19 (Suppl 14) p. 420. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_41B8FD3269F6]
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.
Rohde C., Resch G., Pirnay J.P., Blasdel B.G., Debarbieux L., Gelman D., Górski A., Hazan R., Huys I., Kakabadze E. et al., 2018. Viruses, 10 (4) pp. 1-15. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1F98CD58878]
Genome Sequence of the Pseudomonas protegens Phage ΦGP100.
Vacheron J., Kupferschmied P., Resch G., Keel C., 2018. Genome Announcements, 6 (25) pp. e00261-18. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_051B061D3CD1]
In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria.
Larpin Y., Oechslin F., Moreillon P., Resch G., Entenza J.M., Mancini S., 2018. PloS one, 13 (2) pp. e0192507. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FFBEE644C544]
2017
Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.
Oechslin F., Piccardi P., Mancini S., Gabard J., Moreillon P., Entenza J.M., Resch G., Que Y.A., 2017/03/01. The Journal of infectious diseases, 215 (5) pp. 703-712. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D5FC8128CA16]
 
Computational Prediction of Host-Pathogen Interactions Through Omics Data Analysis and Machine Learning
Carvalho Leite D.M., Brochet X., Resch G., Que Y.A., Neves A., Peña-Reyes C., 2017. Bioinformatics and Biomedical Engineering, 10209 pp. 360-371. Peer-reviewed.
[DOI][WoS][serval:BIB_B23F6461C8EE]
 
Phage Therapy: A New Horizon in the Antibacterial Treatment of Oral Pathogens.
Shlezinger M., Khalifa L., Houri-Haddad Y., Coppenhagen-Glazer S., Resch G., Que Y.A., Beyth S., Dorfman E., Hazan R., Beyth N., 2017. Current topics in medicinal chemistry, 17 (10) pp. 1199-1211. Peer-reviewed.
[DOI][Pmid][serval:BIB_1CA77066BF74]
2016
Comparative Genomics Analysis of Streptococcus tigurinus Strains Identifies Genetic Elements Specifically and Uniquely Present in Highly Virulent Strains.
Diene S.M., François P., Zbinden A., Entenza J.M., Resch G., 2016. PloS one, 11 (8) pp. e0160554. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B14812A32BFE]
The Genome of the Toluene-Degrading Pseudomonas veronii Strain 1YdBTEX2 and Its Differential Gene Expression in Contaminated Sand.
Morales M., Sentchilo V., Bertelli C., Komljenovic A., Kryuchkova-Mostacci N., Bourdilloud A., Linke B., Goesmann A., Harshman K., Segers F. et al., 2016. PloS one, 11 (11) pp. e0165850. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_14197457242A]
2015
Quality and safety requirements for sustainable phage therapy products.
Pirnay J.P., Blasdel B.G., Bretaudeau L., Buckling A., Chanishvili N., Clark J.R., Corte-Real S., Debarbieux L., Dublanchet A., De Vos D. et al., 2015. Pharmaceutical Research, 32 (7) pp. 2173-2179.
[URN][DOI][WoS][Pmid][serval:BIB_2CDEAF7F3438]
2013
 
Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.
Vouillamoz J., Entenza J.M., Giddey M., Fischetti V.A., Moreillon P., Resch G., 2013. International Journal of Antimicrobial Agents, 42 (5) pp. 416-421.
[DOI][WoS][Pmid][serval:BIB_F47E9D5C75C0]
Human-to-bovine jump of Staphylococcus aureus CC8 is associated with the loss of a β-hemolysin converting prophage and the acquisition of a new staphylococcal cassette chromosome.
Resch G., François P., Morisset D., Stojanov M., Bonetti E.J., Schrenzel J., Sakwinska O., Moreillon P., 2013. PLoS One, 8 (3) pp. e58187.
[URN][DOI][WoS][Pmid][serval:BIB_D2A0A1059238]
 
In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia.
Oechslin F., Daraspe J., Giddey M., Moreillon P., Resch G., 2013. Antimicrobial Agents and Chemotherapy, 57 (12) pp. 6276-6283.
[DOI][WoS][Pmid][serval:BIB_F9AED7358FB3]
2012
 
Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes.
Ythier M., Resch G., Waridel P., Panchaud A., Gfeller A., Majcherczyk P., Quadroni M., Moreillon P., 2012. Molecular and Cellular Proteomics, 11 (11) pp. 1123-1139. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ED98E07ED10F]
2011
 
A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance.
Resch G., Moreillon P., Fischetti V.A., 2011. International Journal of Antimicrobial Agents, 38 (6) pp. 516-521.
[DOI][WoS][Pmid][serval:BIB_093242ED7AD8]
PEGylating a bacteriophage endolysin inhibits its bactericidal activity.
Resch G., Moreillon P., Fischetti V.A., 2011. AMB Express, 1 p. 29.
[URN][DOI][WoS][Pmid][serval:BIB_2134A42564B3]
2004
 
Complete genomic nucleotide sequence of the temperate bacteriophage Aa Phi 23 of Actinobacillus actinomycetemcomitans.
Resch G., Kulik E.M., Dietrich F.S., Meyer J., 2004. Journal of Bacteriology, 186 (16) pp. 5523-5528. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B7E3FEDECA4]
2003
 
Ribotypisierung von Fusobacterium nucleatum-Isolaten aus parodontal gesunden und erkrankten Probanden
Berres F., Resch G., Ruppert M., Meyer J., Kulik E.M., 2003. Schweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia, 113 (9) pp. 953-957.
[Pmid][serval:BIB_0812AC167184]
2002
 
Les bacteriophages, nouvelle perspective dans le traitement des maladies infectieuses?
Resch G., Meyer J., 2002. Schweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia, 112 (6) pp. 643-645.
[Pmid][serval:BIB_642E9E917FEE]
1999
 
Effet d'une mise en orthostatisme sur l'hemodynamique veineuse chez le rat apres trois semaines de suspension [Effect of upright tilt on venous hemodynamics in rat after three-week tail suspension]
Louisy F., Tran C.C., Resch G., Lemarquer-Domagala F., Finet M., 1999. Travaux scientifiques des chercheurs du Service de sante des armees durant l'annee ..., 20 pp. 173-174. Peer-reviewed.
[Pmid][serval:BIB_DBB1455C4817]
1998
 
The venous tone is not altered after three-week tail suspension in rats.
Louisy F., Tran C.C., Resch G., Luce P., Lemarquer F., Finet M., 1998. Journal of Gravitational Physiology, 5 (1) pp. P47-8. Peer-reviewed.
[Pmid][serval:BIB_2D59AB480D99]
 
Venous tone and repeated +Gz accelerations.
Tran C.C., Louisy F., Resch G., Luce P., Lemarquer F., Finet M., 1998. Journal of Gravitational Physiology, 5 (1) pp. P35-6. Peer-reviewed.
[Pmid][serval:BIB_75D083CBE051]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University